You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

GENESA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Genesa, and when can generic versions of Genesa launch?

Genesa is a drug marketed by Gensia Automedics and is included in one NDA.

The generic ingredient in GENESA is arbutamine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the arbutamine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for GENESA?
  • What are the global sales for GENESA?
  • What is Average Wholesale Price for GENESA?
Summary for GENESA
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 11
Patent Applications: 249
DailyMed Link:GENESA at DailyMed
Drug patent expirations by year for GENESA

US Patents and Regulatory Information for GENESA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GENESA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 ⤷  Sign Up ⤷  Sign Up
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 ⤷  Sign Up ⤷  Sign Up
Gensia Automedics GENESA arbutamine hydrochloride INJECTABLE;INJECTION 020420-001 Sep 12, 1997 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for GENESA

See the table below for patents covering GENESA around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0329464 Système pour l'administration en boucle fermée d'un medicament simulateur d'exercices. (System for the closed-loop administration of an exercise simulating agent.) ⤷  Sign Up
Norway 890704 ⤷  Sign Up
Japan H10276991 CLOSED SYSTEM DRUG DELIVERY SYSTEM ⤷  Sign Up
Spain 2111973 ⤷  Sign Up
Finland 890776 ⤷  Sign Up
Australia 634152 ⤷  Sign Up
Spain 2081299 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.